Home > Clinical Trials

Saved trials

Completed
NCT03723681
Study of Quizartinib in Combination With Standard Therapies in Chinese Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
7 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Acute Myeloid Leukemia (AML)
Recruiting
NCT04171726
Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation
100 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Aortic Valve Stenosis
Completed
NCT03395639
Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
168 Enrollment(s)
48 Study location(s)
Interventional (Phase III)
Cardiac Disease
Completed
NCT05262322
Study to Evaluate the Use of Direct Oral Anticoagulants in UK Clinical Practice For Patients With a First Stroke Attributable to Nonvalvular Atrial Fibrillation
234 Enrollment(s)
8 Study location(s)
Observational
Atrial Fibrillation
Recruiting
NCT05359224
Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm
406 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Intracranial Aneurysm
Active, not recruiting
NCT04519944
Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
1,200 Enrollment(s)
66 Study location(s)
Observational
Non-valvular Atrial Fibrillation
Completed
NCT04459598
A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Participants
32 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Healthy Subjects
Drug-drug Interaction
Pharmacokinetics
Quizartinib
Recruiting
NCT05320627
Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation
120 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Non-Valvular Atrial Fibrillation